CELH
Get informed when a big investor buys or sells
+ FollowUndervalued by 155.4% based on the discounted cash flow analysis.
| Market cap | $8.53 Billion |
|---|---|
| Enterprise Value | $8.64 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.25 |
| Beta | 0.92 |
| Outstanding Shares | 254,806,000 |
| P/E Ratio | 158.86 |
|---|---|
| PEG | -250.07 |
| Price to Sales | 3.21 |
| Price to Book Ratio | 3.21 |
| Enterprise Value to Revenue | 2.83 |
| Enterprise Value to EBIT | 49.26 |
| Enterprise Value to Net Income | 121 |
| Total Debt to Enterprise | 0.09 |
| Debt to Equity | 0.62 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.5806▲ 0.11% |
|---|---|
| Total Calls | 21,057,600▲ 63.26% |
| Total Puts | 12,226,000▲ 63.57% |
Holdings and activity of institutional investors.
| Ownership % | 67.54%▲ 5.85% |
|---|---|
| Total Invested | $5.17B▼ 11.26% |
| Investors Holding | 595▼ 37.00% |
No data
Celsius Holdings, Inc., is a global company with a proprietary, clinically proven formula for its master brand CELSIUS® and all its sub-brands. A lifestyle fitness drink and a pioneer in the rapidly growing performance energy sector, CEL...